Food & Drug Administration (FDA-d)
In line with FDA guidance that clinicians monitor for new or worsening depression, suicidal thoughts, or unusual changes in mood during GLP-1 RA treatment [46], brief psychological screening should be incorporated at baseline and repeated at intervals during treatment at weeks 6, 12, and 24, and then at least every six months
Telehealth, monitoring, and safety steps to demand Whenever you consider GLP-1 therapy, insist on: A licensed medical evaluation and ongoing follow-up
This article explains why this can happen, whats likely temporary, and how we can help protect and restore your hair while you stay on track with your health goals
Over eight months, she lost 31 lb (14 kg), but the results came with effort and commitment
Henry Meds offers options ranging from daily liraglutide injections to weekly semaglutide, plus non-injectable forms like tablets, capsules, and sublingual semaglutide